Skip to main content

In the News

“Dr. Greengard, 85, is still making breakthroughs. In an offshoot of his award-winning research, the director of the Fisher Center for Alzheimer’s Research recently discovered a new pathway for potentially treating the disease. He identified a protein in mice that stimulates the production of beta amyloid, a substance that forms plaque in the brain and disrupts memory and other cognitive functions. And in an interesting development, he found that a cancer drug, Gleevec, disarms the protein.”